Stock listing
Lang & Schwarz:A2DSS6 Imaging Biometrics Limited Aktie
German listing (Lang & Schwarz) of Imaging Biometrics Limited · home listing LSE:IBAI
Follow Imaging Biometrics Limited into a list and get an email when it puts out news.
Home listing price · LSE:IBAI
0.70p GBX (pence) -0.05 (-6.7%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, LSE:IBAI
- Day range
- 0.65p – 0.728p GBX (pence)Nov 20, 2026
- Volume
- 317,000 sharesNov 20, 2026
- Market cap
- £1.73M GBPAt the close on Nov 20, 2026 · price × 246.7M shares outstanding
- 52-week range
- 0.40p – 1.45p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- £3,750 GBPMedian day 147,160 shares · 3 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:IBAI · Home | 0.70p GBX (pence) | -0.05 (-6.7%) | 317,000 | 0.70p | 0.728p | 0.65p | 0.75p | Close on Nov 20, 2026 |
| Frankfurt:5Y1 | €0.0010 EUR | 0.0000 (0.0%) | — | €0.0010 | €0.0010 | €0.0010 | €0.0010 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:IBAI · GBX (pence), adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.70p | -0.05 | -6.7% | 0.70p | 0.728p | 0.65p | 317,000 | |
| 0.75p | +0.025 | +3.4% | 0.725p | 0.75p | 0.70p | 124,107 | |
| 0.725p | 0.00 | 0.0% | 0.725p | 0.725p | 0.70p | 147,160 | |
| 0.725p | 0.00 | 0.0% | 0.725p | 0.725p | 0.70p | 5,000 | |
| 0.725p | +0.025 | +3.6% | 0.725p | 0.738p | 0.703p | 13,084 | |
| 0.70p | -0.025 | -3.4% | 0.725p | 0.75p | 0.70p | 71,654 | |
| 0.725p | +0.04 | +5.8% | 0.725p | 0.75p | 0.703p | 9,110 | |
| 0.685p | -0.04 | -5.5% | 0.725p | 0.74p | 0.685p | 11,965 | |
| 0.725p | 0.00 | 0.0% | 0.725p | 0.74p | 0.725p | 50,000 | |
| 0.725p | 0.00 | 0.0% | 0.725p | 0.75p | 0.725p | 1 | |
| 0.725p | 0.00 | 0.0% | 0.725p | 0.745p | 0.70p | 35,890 | |
| 0.725p | -0.075 | -9.4% | 0.80p | 0.85p | 0.71p | 439,648 | |
| 0.80p | 0.00 | 0.0% | 0.80p | 0.80p | 0.70p | 763,170 | |
| 0.80p | 0.00 | 0.0% | 0.80p | 0.80p | 0.704p | 71,449 | |
| 0.80p | -0.075 | -8.6% | 0.845p | 0.845p | 0.80p | 732,500 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.875p | 1 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.79p | 154,468 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.90p | 0.875p | 50,000 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.80p | 87,185 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.80p | 461,873 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.80p | 70,001 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.922p | 0.79p | 21,141 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.845p | 222,323 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.80p | 344,569 | |
| 0.875p | +0.085 | +10.8% | 0.875p | 0.95p | 0.80p | 227,412 | |
| 0.79p | -0.085 | -9.7% | 0.875p | 0.92p | 0.79p | 451,590 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.932p | 0.80p | 107,747 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.875p | 0.875p | 0 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.875p | 0.863p | 139,473 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.934p | 0.875p | 50,000 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.94p | 0.875p | 24,000 | |
| 0.875p | -0.10 | -10.3% | 0.975p | 0.98p | 0.86p | 389,388 | |
| 0.975p | 0.00 | 0.0% | 0.975p | 0.975p | 0.92p | 33,195 | |
| 0.975p | -0.025 | -2.5% | 1.00p | 1.035p | 0.90p | 609,337 | |
| 1.00p | 0.00 | 0.0% | 1.00p | 1.08p | 0.904p | 1,426,432 | |
| 1.00p | +0.10 | +11.1% | 0.95p | 1.45p | 0.90p | 8,957,753 | |
| 0.90p | +0.09 | +11.1% | 0.90p | 1.00p | 0.80p | 261,089 | |
| 0.81p | -0.09 | -10.0% | 0.90p | 1.00p | 0.81p | 59,835 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 1.00p | 0.80p | 55,421 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 1.00p | 0.855p | 345,193 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 0.90p | 0.90p | 20,000 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 1.00p | 0.80p | 347,579 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 0.975p | 0.83p | 479,919 | |
| 0.90p | +0.10 | +12.5% | 0.80p | 1.00p | 0.72p | 1,797,283 | |
| 0.80p | +0.025 | +3.2% | 0.775p | 0.90p | 0.70p | 156,059 | |
| 0.775p | 0.00 | 0.0% | 0.775p | 0.90p | 0.775p | 122,732 | |
| 0.775p | 0.00 | 0.0% | 0.775p | 0.88p | 0.775p | 45,912 | |
| 0.775p | +0.14 | +22.0% | 0.775p | 0.90p | 0.685p | 585,764 | |
| 0.635p | -0.065 | -9.3% | 0.70p | 0.80p | 0.635p | 677,673 | |
| 0.70p | 0.00 | 0.0% | 0.70p | 0.78p | 0.70p | 2 | |
| 0.70p | 0.00 | 0.0% | 0.70p | 0.70p | 0.70p | 0 | |
| 0.70p | 0.00 | 0.0% | 0.70p | 0.70p | 0.625p | 17,412 | |
| 0.70p | -0.05 | -6.7% | 0.70p | 0.70p | 0.625p | 293,374 | |
| 0.75p | -0.05 | -6.3% | 0.80p | 0.824p | 0.70p | 760,521 | |
| 0.80p | +0.085 | +11.9% | 0.80p | 0.875p | 0.72p | 367,392 | |
| 0.715p | -0.085 | -10.6% | 0.725p | 0.725p | 0.70p | 274,993 | |
| 0.80p | 0.00 | 0.0% | 0.80p | 0.825p | 0.72p | 337,569 | |
| 0.80p | +0.065 | +8.8% | 0.80p | 0.90p | 0.675p | 643,898 | |
| 0.735p | +0.035 | +5.0% | 0.725p | 1.00p | 0.70p | 2,214,195 | |
| 0.70p | +0.065 | +10.2% | 0.70p | 0.74p | 0.61p | 819,331 | |
| 0.635p | 0.00 | 0.0% | 0.635p | 0.635p | 0.635p | 0 | |
| 0.635p | -0.065 | -9.3% | 0.70p | 0.733p | 0.635p | 186,940 | |
| 0.70p | +0.10 | +16.7% | 0.70p | 0.735p | 0.60p | 265,994 | |
| 0.60p | -0.10 | -14.3% | 0.70p | 0.719p | 0.60p | 135,952 | |
| 0.70p | 0.00 | 0.0% | 0.70p | 0.719p | 0.70p | 6,955 |
- Ticker
- Lang & Schwarz:A2DSS6
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 1, 2026
Strengthening pipeline prominent US institutions
Latest news
Strengthening pipeline prominent US institutions
Oct 1, 2026
Closed 1.00p (+11.1%) on Oct 1, 2026
Adoption of Advanced Brain Tumor Imaging Platform
Sep 15, 2026
Closed 0.775p (+22.0%) on Sep 15, 2026
US Academic Medical Centre Adopts IB Clinic
Aug 28, 2026
Closed 0.735p (+5.0%) on Aug 28, 2026
Half Yearly Report to 30 June 2026
Jul 29, 2026
Closed 0.60p (0.0%) on Jul 29, 2026
Sub-division
Jul 14, 2026
Closed 0.60p (0.0%) on Jul 14, 2026
Publication of Phase 1 Clinical Trial
Jun 9, 2026
Closed 0.775p (-3.1%) on Jun 9, 2026
Commercialisation, Phase II Results & Revenue Path
Jun 5, 2026
Closed 0.70p (+16.7%) on Jun 5, 2026
AGM Statement and Business Update
Jun 3, 2026
Closed 0.60p (0.0%) on Jun 3, 2026
Amendement to Notice of annual general meeting
May 13, 2026
Closed 0.575p (0.0%) on May 13, 2026
Notice of annual general meeting
May 12, 2026
Closed 0.575p (0.0%) on May 12, 2026
Imaging Biometrics Limited on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 18 in the last 12 months · 158 in all · newest Oct 1, 2026 · oldest 2018
Where Imaging Biometrics Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:IBAI · Home listing | LSE | United Kingdom | GBX |
| Lang & Schwarz:A2DSS6 · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2DSS6 | LS Exchange | Germany | EUR |
| Frankfurt:5Y1 | Frankfurt | Germany | EUR |
| gettex:5Y1 | gettex | Germany | EUR |
| Munich:5Y1 | Munich | Germany | EUR |
| Stuttgart:5Y1 | Stuttgart | Germany | EUR |
Valuation
EV/sales 2.4× against a median of 0.6×: 8th lowest of 9 Health care services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- £1.86M GBP
- P/E
- Loss
- EV/sales
- 2.4×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 5.6×
- Gross margin
- 82.0%
- Operating margin
- −19.9%
- Net margin
- −50.9%
- Debt to equity
- 0.6×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Imaging Biometrics Limited · LSE:IBAI | US$2.26M | US$2.43M | n/a | 2.4× | n/a | 5.6× | −50.9% | 0.6× | n/a |
| Healthcare Triangle, Inc. · NASDAQ:HCTI | US$2.63M | US$17.54M | n/a | 0.6× | n/a | 0.1× | −56.4% | 0.3× | 2.08 |
| Monsenso A/S · OMXCOP:MONSO | US$2.57M | US$2.69M | n/a | 2.1× | n/a | 2.6× | −81.0% | 0.1× | n/a |
| Visionflex Group Limited · ASX:VFX | US$2.30M | US$1.61M | n/a | 0.6× | n/a | n/a | −1.4% | n/a | n/a |
| Feedback plc · LSE:FDBK | US$2.24M | −US$2.77M | n/a | −2.4× | n/a | 0.4× | −826.2% | 0.0× | n/a |
| Predilife SA · EURONEXT:ALPRE | US$2.16M | US$7.61M | n/a | 6.2× | n/a | n/a | −315.3% | n/a | n/a |
| RMH Holdings Limited · HKEX:8437 | US$2.12M | US$2.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| INVO Fertility, Inc. · NASDAQ:IVF | US$2.10M | US$3.06M | n/a | 0.4× | n/a | 0.1× | −71.4% | 0.1× | 1.62 |
| HealthLynked Corp. · OTC:HLYK | US$2.07M | US$2.05M | n/a | 1.8× | n/a | n/a | −351.6% | n/a | -0.67 |
| Grey Matters Health Inc · CSE:GREY | US$1.98M | US$1.95M | n/a | n/a | n/a | 1.6× | n/a | 0.0× | 0.43 |
| Global Health Limited · ASX:GLH | US$1.95M | US$2.54M | n/a | 0.5× | n/a | n/a | −10.5% | n/a | n/a |
| Median of the others | US$2.14M | US$2.56M | 0.6× | 0.4× | −76.2% | 0.1× | 1.03 |
Team and board
Officers
| Officer | Role |
|---|---|
| Trevor Brown | Chairman and CEO |
Board
| Director | Role |
|---|---|
| Trevor Brown | Chairman and CEO |
| Al Musella | Member of the Board of Directors |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of new ordinary shares Announced: £250,000 · £0.01 a share · Peterhouse Capital Limited Dealers: Peterhouse Capital Limited (lead) Buyers: Braveheart Investment Group plc (7,000,000 Placing Shares for £70,000; will hold 72,415,862 shares, 29.35% of enlarged share capital) Use of proceeds: Clinical trials of GaM and the Expanded Access Program, completing IB Clinic and IB Nimble releases, and expanding marketing and sales teams | Mar 18, 2025 | US$324,645 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in GBP
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 788.1K | 750.1K | 609.4K | 535.9K | 521.1K | 255.3K | 272.9K | 165.0K | ||
| Cost of revenue | 142.0K | 7.77K | 127.0K | 1.78K | 17.0K | 8.55K | 4.36K | 35.0K | ||
| Gross profit | 646.1K | 687.9K | 482.4K | 534.1K | 504.0K | 246.8K | 263.5K | 130.0K | ||
| Research and development | 69.0K | 112.1K | 62.1K | 46.7K | ||||||
| Selling, general and administrative | 894.4K | 1.07M | 1.00M | 1.04M | 994.4K | 933.5K | 859.2K | 878.6K | 258.0K | 272.0K |
| Operating income | -157.1K | -327.5K | -406.3K | -500.9K | -490.3K | -685.7K | -617.3K | -579.5K | -258.0K | -272.0K |
| Depreciation and amortization | 91.2K | 54.5K | 115.4K | 140.6K | 133.5K | 116.5K | 111.0K | 33.5K | 257.7K | 272.0K |
| EBITDA | -66.0K | -273.0K | -290.9K | -360.3K | -356.9K | -569.2K | -506.3K | -546.0K | -276 | 0 |
| Interest expense | 2.32K | 9.87K | 10.7K | 10.7K | 31.8K | 29.0K | 15.7K | 23.0K | 31.0K | |
| Income before tax | -400.9K | -327.1K | -623.8K | -511.6K | -501.1K | -717.5K | -638.7K | -595.2K | -281.0K | -297.0K |
| Net income | -400.9K | -327.1K | -623.8K | -511.6K | -501.1K | -717.5K | -638.7K | -764.1K | -281.0K | -303.0K |
| Earnings per share, basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 112.6K | 53.5K | 138.8K | 314.0K | 728.6K | 478.9K | 865.9K | 28.8K | 387.0K | 66.0K |
| Receivables | 137.5K | 165.1K | 140.1K | 161.0K | 49.5K | 36.9K | 17.2K | 44.1K | ||
| Inventory | 44.9K | 0 | ||||||||
| Current assets | 335.1K | 251.5K | 306.8K | 511.3K | 806.8K | 542.5K | 1.30M | 94.4K | 398.0K | 80.0K |
| Goodwill | 165.6K | 72.6K | 71.4K | 220.2K | 205.2K | 204.1K | 128.3K | 201.3K | 248.0K | |
| Total assets | 1.01M | 929.7K | 720.7K | 1.27M | 1.58M | 1.43M | 1.87M | 1.02M | 693.0K | 80.0K |
| Accounts payable | 12.3K | 233.2K | 8.74K | 12.7K | 11.8K | 31.3K | ||||
| Current liabilities | 606.5K | 627.1K | 625.8K | 560.5K | 392.8K | 361.6K | 208.9K | 254.9K | 103.0K | 52.0K |
| Total debt | 172.3K | 62.2K | 55.4K | 93.3K | 58.0K | 62.9K | 4.00K | 375.0K | ||
| Total liabilities | 778.8K | 627.1K | 625.8K | 560.5K | 392.8K | 361.6K | 208.9K | 254.9K | 103.0K | 427.0K |
| Shareholders' equity | 235.3K | 302.5K | 94.9K | 707.1K | 1.19M | 1.07M | 1.66M | 762.9K | 590.0K | 28.0K |
| Shares outstanding | 241.5M | 218.0M | 183.7M | 182.6M | 172.8M | 148.0M | 128.2M | 93.6M | 49.9M | 29.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 74.3K | -136.2K | -96.8K | -374.7K | -288.8K | -423.2K | -524.6K | -683.7K | -211.0K | -256.0K |
| Capital spending | -4 | -309.0K | -78.4K | -39.9K | -56.6K | -31.6K | -116.2K | -32.9K | -47.0K | 0 |
| Free cash flow | 74.3K | -136.2K | -175.2K | -414.6K | -345.3K | -454.9K | -640.8K | -716.5K | -258.0K | -256.0K |
| Cash from investing | -255.5K | -309.0K | -78.4K | -39.9K | -56.6K | -31.6K | -116.2K | -137.2K | -47.0K | |
| Cash from financing | 240.3K | 359.9K | 595.0K | 67.9K | 1.48M | 454.4K | 579.0K | |||
| Change in cash | 59.1K | -85.3K | -175.2K | -414.6K | 249.7K | -387.0K | 837.1K | -358.2K | 321.0K | -256.0K |
Cap table
Built by 6ix from Imaging Biometrics Limited’s releases · as of Mar 18, 2025
- Common shares
- 246,709,789
- Fully diluted
- 246,709,789
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 246,709,789 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 246,709,789 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Trevor Brown Other companies: Autins Group PLC (Non-executive Director · Since at least Nov 19, 2025); Truetide plc (Chief Executive Officer · Until Jun 24, 2026 · Past) | Chairman and CEO · Since at least Sep 15, 2026 |
| Al Musella | Member of the Board of Directors · Since at least Nov 10, 2025 |
| John Charles Richardson | Non-executive Director · Feb 19, 2026 – Nov 5, 2026 · Past |
Log in to ask 6ix AI your own questions about Imaging Biometrics Limited.